Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Luisa F. Escobar‐Hoyos, Alex Penson, Ram Kannan, et al.
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 198-211.e8
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 597
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 264
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 249
Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
Eduardo Alvarado-Ortiz, Karen Griselda de la Cruz-López, Jared Becerril-Rico, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 130
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 57
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
NRAS mutant melanoma: Towards better therapies
Tijana Randic, Ines Kozar, Christiane Margue, et al.
Cancer Treatment Reviews (2021) Vol. 99, pp. 102238-102238
Open Access | Times Cited: 99
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program
Kathryn Bieging-Rolett, Alyssa M. Kaiser, David W. Morgens, et al.
Molecular Cell (2020) Vol. 80, Iss. 3, pp. 452-469.e9
Open Access | Times Cited: 82
The Function of the Mutant p53-R175H in Cancer
Yen-Ting Chiang, Yi‐Chung Chien, Yuheng Lin, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4088-4088
Open Access | Times Cited: 67
Cancer Stemness: p53 at the Wheel
Dishari Ghatak, Damayanti Das Ghosh, Susanta Roychoudhury
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 61
KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer
Yuming Luo, Zhihua Li, Yao Kong, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 41
Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer
Ledong Wan, Kuan‐Ting Lin, Mohammad Alinoor Rahman, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1678-1695
Open Access | Times Cited: 40
Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism
Zhenyi Su, Ning Kon, Jingjie Yi, et al.
Nature Cancer (2023) Vol. 4, Iss. 4, pp. 564-581
Open Access | Times Cited: 33
A prime editor mouse to model a broad spectrum of somatic mutations in vivo
Zackery A. Ely, Nicolas Mathey‐Andrews, Santiago Naranjo, et al.
Nature Biotechnology (2023)
Open Access | Times Cited: 30
RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yufang Bao, Sirui Zhang, Xiaoyu Zhang, et al.
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1490-1502
Open Access | Times Cited: 23
An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer
Lingping Kong, Fanlu Meng, Ping Zhou, et al.
Science Bulletin (2024) Vol. 69, Iss. 13, pp. 2122-2135
Open Access | Times Cited: 14
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101411-101411
Open Access | Times Cited: 11
Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Yiru Zhou, Yeye Kuang, Chan Wang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1947-1964
Open Access | Times Cited: 11
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Xu Zhou, Kai Hu, Peter J. Bailey, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 50
MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors
Laura M. Urbanski, Mattia Brugiolo, SungHee Park, et al.
Cell Reports (2022) Vol. 41, Iss. 8, pp. 111704-111704
Open Access | Times Cited: 37
TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
Yin Kau Lam, Jianqing Yu, Hao Huang, et al.
Hepatology (2022) Vol. 78, Iss. 3, pp. 727-740
Open Access | Times Cited: 31
Novel Approach to Enriching Glycosylated RNAs: Specific Capture of GlycoRNAs via Solid-Phase Chemistry
Jiajia Li, Shuang Yue, Ziyuan Gao, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 32, pp. 11969-11977
Closed Access | Times Cited: 23
Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression
Riyue Feng, Yin Yin, Yuge Wei, et al.
Cancer Letters (2023) Vol. 562, pp. 216154-216154
Closed Access | Times Cited: 21
Steering research on mRNA splicing in cancer towards clinical translation
Olga Anczuków, Frédéric H.‐T. Allain, Brittany Angarola, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 887-905
Closed Access | Times Cited: 7
Mutant p53 in cell-cell interactions
Steven E. Pilley, Tristan A. Rodríguez, Karen H. Vousden
Genes & Development (2021) Vol. 35, Iss. 7-8, pp. 433-448
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top